FDA Removes Risk Evaluation & Mitigation Strategies Program For Antipsychotic Drug Clozapine
ReutersAug 27, 2025 3:38 PM
Aug 27 (Reuters) - FDA:
FDA: REMOVES RISK EVALUATION AND MITIGATION STRATEGIES PROGRAM FOR ANTIPSYCHOTIC DRUG CLOZAPINE
FDA: REMS NO LONGER NECESSARY TO ENSURE BENEFITS OF CLOZAPINE OUTWEIGH RISK OF SEVERE NEUTROPENIA
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Decoding Wall Street’s Q2 2025 Playbook
TradingKey - In Q2 2025, the S&P 500 achieved an 11% increase, reaching an all-time high, signaling a robust bull market. However, this rally was highly concentrated, driven primarily by a small group of technology stocks, while other sectors experienced limited growth or declines.TradingKey
12 hours ago
CrowdStrike 2025Q2 Earnings Preview: Well-Positioned for AI Innovations
TradingKey - CrowdStrike will release its earnings for the second quarter of the fiscal 2025 on August 27th after the bell.Overall, CRWD stock has been outperforming the broad market by being up 20% since the beginning of the year, however after July it has been in a constant decline.TradingKey
17 hours ago
Nvidia Q2 Earnings Expectations: With Little Room for Error, Will China-Related Risks Be Magnified?
TradingKey - Ahead of Nvidia Q2 FY2026 earnings report, multiple Wall Street firms have raised their price targets on Nvidia, reflecting strong confidence in AI demand. While analysts continue to forecast robust ~50% year-over-year growth in revenue and EPS, the China variable remains a major riskTradingKey
Tue, Aug 26
What to Watch in Nvidia’s Q2 FY2026 Earnings: AI Growth, Margins, and Market Impact
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) will report its Q2 FY2026 earnings on Wednesday, August 27, 2025, after the U.S. market closes. The earnings call is scheduled for 5:00 p.m. Eastern Time. With Nvidia being a bellwether in AI, gaming, and data center markets, and carrying significant...TradingKey
Mon, Aug 25
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
